These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1869525

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of phorbol esters on iron uptake in human hematopoietic cell lines.
    Testa U, Titeux M, Louache F, Thomopoulos P, Rochant H.
    Cancer Res; 1984 Nov; 44(11):4981-6. PubMed ID: 6091866
    [Abstract] [Full Text] [Related]

  • 23. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
    Yamamoto-Yamaguchi Y, Makishima M, Kanatani Y, Kasukabe T, Honma Y.
    Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
    [Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor-alpha production-inhibiting activity of phthalimide analogues on human leukemia THP-1 cells and a structure-activity relationship study.
    Miyachi H, Ogasawara A, Azuma A, Hashimoto Y.
    Bioorg Med Chem; 1997 Nov; 5(11):2095-102. PubMed ID: 9416426
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells.
    Hass R, Lonnemann G, Männel D, Topley N, Hartmann A, Köhler L, Resch K, Goppelt-Strübe M.
    Leuk Res; 1991 Nov; 15(5):327-39. PubMed ID: 1904515
    [Abstract] [Full Text] [Related]

  • 27. Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha.
    Diaz A, Reginato AM, Jimenez SA.
    J Biol Chem; 1992 May 25; 267(15):10816-22. PubMed ID: 1587858
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE, Dinarello CA.
    Cancer Res; 1991 May 01; 51(9):2379-85. PubMed ID: 2015601
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of transferring binding and iron uptake of hematopoietic cell lines by phorbol esters.
    Pelicci PG, Testa U, Thomopoulos P, Tabilio A, Vainchenker W, Titeux M, Gourdin MF, Rochant H.
    Leuk Res; 1984 May 01; 8(4):597-609. PubMed ID: 6088899
    [Abstract] [Full Text] [Related]

  • 30. Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells.
    Winzen R, Wallach D, Engelmann H, Nophar Y, Brakebusch C, Kemper O, Resch K, Holtmann H.
    J Immunol; 1992 Jun 01; 148(11):3454-60. PubMed ID: 1316917
    [Abstract] [Full Text] [Related]

  • 31. Induction of monocytic differentiation by tumor necrosis factor in phorbol ester-resistant KG-1a cells.
    Kharbanda S, Nakamura T, Datta R, Sherman ML, Kufe D.
    Cancer Commun; 1990 Jun 01; 2(10):327-32. PubMed ID: 1698425
    [Abstract] [Full Text] [Related]

  • 32. A differential effect of phorbol ester on the internalization of iron and transferrin by HL 60 cells.
    Sharma RJ, Grant DA.
    Biochem Soc Trans; 1990 Oct 01; 18(5):1005-6. PubMed ID: 2083630
    [No Abstract] [Full Text] [Related]

  • 33. Decrease in CuZn-superoxide dismutase mRNA level during differentiation of human monocytic and promyelotic leukemia cells.
    Saito H, Kuroki T, Nose K.
    FEBS Lett; 1989 Jun 05; 249(2):253-6. PubMed ID: 2737285
    [Abstract] [Full Text] [Related]

  • 34. Expression of 85-kDa protein of adriamycin-resistant tumor cells during hematopoietic differentiation of THP-1 and HEL cells.
    Ishii S, Naito M, Masuda M, Tsuruo T.
    Jpn J Cancer Res; 1992 Jan 05; 83(1):107-12. PubMed ID: 1371989
    [Abstract] [Full Text] [Related]

  • 35. Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.
    Roulston A, Beauparlant P, Rice N, Hiscott J.
    J Virol; 1993 Sep 05; 67(9):5235-46. PubMed ID: 8394446
    [Abstract] [Full Text] [Related]

  • 36. Thromboxane release by lymphokine-differentiated U937 human monocytic cells: response to platelet-activating factor (PAF) and chemotactic peptide (FMLP) but not to low affinity IGE-receptor (Fc epsilon RII/CD23) occupation.
    Storch J, Edwards RJ, MacDermot J.
    J Leukoc Biol; 1990 Sep 05; 48(3):266-73. PubMed ID: 2144015
    [Abstract] [Full Text] [Related]

  • 37. M-CSF and 1,25 dihydroxy vitamin D3 synergize with 12-O-tetradecanoylphorbol-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells.
    Bhatia M, Kirkland JB, Meckling-Gill KA.
    Leukemia; 1994 Oct 05; 8(10):1744-9. PubMed ID: 7934171
    [Abstract] [Full Text] [Related]

  • 38. Interleukin 6 induces DNA binding activity of AP1 in M1 myeloblastic cells but not in a growth resistant cell derivative.
    Melamed D, Resnitzky D, Haimov I, Levy N, Pfarr CM, Yaniv M, Kimchi A.
    Cell Growth Differ; 1993 Aug 05; 4(8):689-97. PubMed ID: 8398910
    [Abstract] [Full Text] [Related]

  • 39. Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.
    Bloch A.
    Leukemia; 1993 Aug 05; 7(8):1219-24. PubMed ID: 8350621
    [Abstract] [Full Text] [Related]

  • 40. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB, Mason SN.
    Cancer Res; 1991 Feb 15; 51(4):1202-9. PubMed ID: 1997162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.